Glonghui, May 6 | Poinsettia (300723.SZ) increased its increase in the afternoon. It now rose 8.18% to 24.6 yuan. The temporary transaction was 140 million yuan, and the latest market value was 11.17 billion yuan. Yipinhong announced this afternoon that its wholly-owned subsidiary Guangzhou Yipinhong Pharmaceutical recently obtained a registration certificate for the oral suspension of oxazepine. Oxcarbazepine oral suspension is suitable for treating primary generalized tonic-clonic seizures and partial seizures, with or without secondary generalized seizures. It is suitable for adults and children over 2 years of age, and can be used alone or in combination with other anticonvulsants.
A股异动丨一品红涨超8% 全资子公司获得奥卡西平口服混悬液注册证书
A-share changes丨Yipinhong's wholly-owned subsidiary obtained an ocaxipine oral suspension registration certificate with an increase of more than 8%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.